{
    "eid": "2-s2.0-84890488736",
    "title": "Overview of lupus nephritis management guidelines and perspective from Asia",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Nephrology",
            "@code": "2727"
        }
    ],
    "keywords": [
        "Asia",
        "lupus",
        "nephritis"
    ],
    "authors": [
        "Chi Chiu Mok"
    ],
    "citedby-count": 59,
    "ref-count": 72,
    "ref-list": [
        "Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden",
        "Epidemiology of systemic lupus erythematosus in Asia",
        "Systematic review of the epidemiology of systemic lupus erythematosus in the asia-pacific region: Prevalence, incidence, clinical features, and mortality",
        "Updates on the treatment of lupus nephritis",
        "Lupus nephritis: Current update",
        "Therapy of Lupus Nephritis",
        "Long\u2010term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only",
        "Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis: A Randomized, Controlled Trial",
        "Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis",
        "Successful treatment of class V+IV lupus nephritis with multitarget therapy",
        "A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade",
        "Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria",
        "Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.",
        "Severe lupus nephritis: Racial differences in presentation and outcome",
        "Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis",
        "Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis",
        "Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis",
        "American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis",
        "Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis",
        "Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis",
        "Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the euro-lupus nephritis trial",
        "The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide",
        "Sequential therapy for diffuse proliferative and membranous lupus nephritis: Cyclophosphamide and prednisolone followed by azathioprine and prednisolone",
        "Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine",
        "Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine",
        "Treatment of diffuse proliferative lupus glomerulonephritis: A comparison of two cyclophosphamide-containing regimens",
        "Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis",
        "Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide",
        "Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy",
        "Malignancy in systemic lupus erythematosus: what have we learned?",
        "Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis",
        "Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis",
        "Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis",
        "Cost comparison between mycophenolate mofetil and cyclophosphamide- azathioprine in the treatment of lupus nephritis",
        "Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis",
        "The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus",
        "The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis",
        "Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis",
        "Adverse drug reaction driven immunosuppressive drug manipulations: A single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetil",
        "Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients",
        "Pharmacokinetics of mycophenolic acid in severe lupus nephritis",
        "Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis",
        "Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial",
        "Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis",
        "Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial",
        "Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: The Cyclofa-Lune study",
        "A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus",
        "A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.",
        "Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial",
        "Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose",
        "Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis",
        "Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: An open-label pilot study with five newly diagnosed patients",
        "Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: A prospective multi-centre observational study",
        "Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class v lupus nephritis",
        "Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy",
        "Systematic review and meta-analysis of immunosuppressant therapy clinical trials in membranous lupus nephritis",
        "Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis",
        "Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome",
        "Oral cyclophosphamide for lupus glomerulonephritis: An underused therapeutic option",
        "Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies",
        "Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: A prospective study in daily clinical practice",
        "Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: A non-randomized prospective cohort study",
        "Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis",
        "Proliferation signal inhibitors in the treatment of lupus nephritis: Preliminary experience",
        "Survival analysis and causes of mortality in patients with lupus nephritis",
        "Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment",
        "Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update",
        "Quality of life comparison between corticosteroid-and-mycofenolate mofetil and corticosteroid-and-oral cyclophosphamide in the treatment of severe lupus nephritis",
        "The classification of glomerulonephritis in systemic lupus erythematosus revisited",
        "Irreproducibility of the Activity and Chronicity Indices Limits Their Utility in the Management of Lupus Nephritis",
        "Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring",
        "Lupus nephritis: Induction therapy in severe lupus nephritis-should MMF be considered the drug of choice?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Guangzhou",
            "affilname": "The First Affiliated Hospital, Sun Yat-sen University",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beijing",
            "affilname": "Peking University First Hospital",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shanghai",
            "affilname": "Renji Hospital",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Manila",
            "affilname": "University of Santo Tomas, Manila",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Nanjing",
            "affilname": "Jinling Hospital",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Tokyo",
            "affilname": "Keio University",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hong Kong",
            "affilname": "The University of Hong Kong",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Hong Kong",
            "affilname": "Tuen Mun Hospital",
            "affiliation-country": "China"
        }
    ],
    "funding": []
}